close 77% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. Hinnavahelepingud on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 77% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Palume teil kaaluda, kas hinnavahelepingute süsteem on teile arusaadav ja kas olete valmis võtma riski, mis suure tõenäoususega on kahjumlik.
Change languageEesti
Dashboard
Kodu・Aktsiate loetelu・Roche Holding AG
Search

Roche Holding AG

Suletud

SektorTervishoid

272.6 0.22

Hinna uuendus 18. juuli 2025, 15:19 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

267

Max

274.4

Põhinäitajad

By Trading Economics

Sissetulek

2B

Müük

31B

P/E

Sektori keskmine

26.57

39.857

Dividenditootlus

3.53

Kasumimarginaal

6.588

Töötajad

103,249

EBITDA

6B

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

3.53%

2.42%

Turustatistika

By TradingEconomics

Turukapital

206B

Eelmine avamishind

272.38

Eelmine sulgemishind

272.6

Uudiste sentiment

By Acuity

19%

81%

90 / 376 Pingereas Healthcare

Roche Holding AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. juuni 2025, 08:25 UTC

Omandamised, ülevõtmised, äriostud

EQT, Sanofi Co-Led $135 Million Funding Round for Spanish Biotech Company SpliceBio

DJ

Loe

12. mai 2025, 02:16 UTC

Suurimad hinnamuutused turgudel

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

DJ

Loe

24. apr 2025, 07:30 UTC

Tulu

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

DJ

Loe

24. apr 2025, 05:31 UTC

Tulu

Roche Sales Rise Boosted By Key Drugs

DJ

Loe

9. apr 2025, 09:39 UTC

Suurimad hinnamuutused turgudel

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

DJ

Loe

12. märts 2025, 09:23 UTC

Suurimad hinnamuutused turgudel

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

DJ

Loe

30. jaan 2025, 09:36 UTC

Tulu

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

DJ

Loe

30. jaan 2025, 06:32 UTC

Tulu

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

DJ

Loe

16. juuni 2025, 08:55 UTC

Kuumad aktsiad

Stocks to Watch: Victoria's Secret, Renault, U.S. Steel, Sarepta -- WSJ

DJ

Loe

3. juuni 2025, 07:51 UTC

Market Talk

Roche Unlikely to Get Revenue Boost From Tecentriq Combination With Lurbinectedin -- Market Talk

DJ

Loe

21. mai 2025, 07:20 UTC

Market Talk

Roche Lymphoma Drug Columvi Dealt Setback by FDA Committee -- Market Talk

DJ

Loe

2. mai 2025, 06:25 UTC

Market Talk
Tulu

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

DJ

Loe

24. apr 2025, 09:39 UTC

Market Talk
Tulu

Roche's Pipeline in Focus After Solid Results -- Market Talk

DJ

Loe

24. apr 2025, 09:24 UTC

Market Talk
Tulu

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

DJ

Loe

24. apr 2025, 09:18 UTC

Market Talk
Tulu

Roche's Results Are Solid -- Market Talk

DJ

Loe

24. apr 2025, 05:16 UTC

Peamised uudised

Roche Sales Rise, Boosted By Key Drugs

DJ

Loe

22. apr 2025, 10:51 UTC

Peamised uudised

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

DJ

Loe

15. apr 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

DJ

Loe

9. apr 2025, 10:03 UTC

Market Talk
Tulu

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

DJ

Loe

9. apr 2025, 07:23 UTC

Market Talk

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

DJ

Loe

3. apr 2025, 08:41 UTC

Market Talk

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

DJ

Loe

3. apr 2025, 07:51 UTC

Market Talk

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

DJ

Loe

31. märts 2025, 09:31 UTC

Kuumad aktsiad

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

DJ

Loe

13. märts 2025, 07:46 UTC

Market Talk

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

DJ

Loe

12. märts 2025, 16:34 UTC

Peamised uudised

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

DJ

Loe

12. märts 2025, 08:51 UTC

Market Talk

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

DJ

Loe

12. märts 2025, 08:18 UTC

Market Talk

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

DJ

Loe

13. veebr 2025, 11:43 UTC

Market Talk

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

DJ

Loe

30. jaan 2025, 07:56 UTC

Market Talk
Tulu

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

DJ

Loe

30. jaan 2025, 06:04 UTC

Tulu

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

DJ

Loe

Roche Holding AG Prognoos

Sentiment

By Acuity

90 / 376 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.